AI assistant
Sending…
ELI LILLY & Co — Director's Dealing 2012
Jul 3, 2012
29745_dirs_2012-07-03_83f021ce-a6b3-4467-a187-170d36676cf6.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: LILLY ELI & CO (LLY)
CIK: 0000059478
Period of Report: 2012-07-02
Reporting Person: Conterno Enrique A (Sr. VP & Pres., Lilly Diabetes)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-07-02 | Common Stock | S | 5000 | $43.00 | Disposed | 32012 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 4299 | Indirect |
Footnotes
F1: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 12, 2012.
More from ELI LILLY & Co
Capital/Financing Update
2026
May 20
Report Publication Announcement
2026
May 11
Capital/Financing Update
2026
May 8
Declaration of Voting Results & Voting Rights Announcements
2026
May 7
Capital/Financing Update
2026
May 6
Capital/Financing Update
2026
May 6
Major Shareholding Notification
2026
May 1
Interim / Quarterly Report
2026
Apr 30
Earnings Release
2026
Apr 30
Regulatory Filings
2026
Apr 29